RituximabCOVID-19 infection: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-25200-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：464 / 464

相关论文

共 50 条

[21] RituximabCOVID-19: 2 case report
Reactions Weekly, 2021, 1870 (1) : 281 - 281
[22] RituximabCOVID-19 infection: 3 case reports
Reactions Weekly, 2021, 1846 (1) : 283 - 283
[23] RituximabCOVID-19 infection: 2 case reports
Reactions Weekly, 2022, 1897 (1) : 324 - 324
[24] RituximabCOVID-19 infection: 8 case reports
Reactions Weekly, 2021, 1872 (1) : 440 - 440
[25] Remdesivir/rituximabCOVID-19 infection and COVID-19 infection rebound: case report
Reactions Weekly, 2022, 1927 (1) : 461 - 461
[26] RituximabCOVID-19 infection: 2 case reports
Reactions Weekly, 2020, 1833 (1) : 342 - 342
[27] Prednisone/rituximabCOVID-19 pneumonia: case report
Reactions Weekly, 2021, 1838 (1) : 456 - 456
[28] RituximabCovid-19 infection following exposure during pregnancy: case report
Reactions Weekly, 2023, 1946 (1) : 490 - 490
[29] Bendamustine/rituximabCOVID-19 pneumonia: case report
Reactions Weekly, 2021, 1861 (1) : 72 - 72
[30] RituximabCOVID-19 pneumonia and herpes simplex virus infection: case report
Reactions Weekly, 2022, 1889 (1) : 278 - 278

← 1 2 3 4 5 →